Summary

Persistence Market Research has recently released a comprehensive report on the global Pneumonia Diagnostics market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.

Key Insights

- Pneumonia Diagnostics Market Size (2026E): US$ 2.5 Bn
- Projected Market Value (2033F): US$ 4.1 Bn
- Global Market Growth Rate (CAGR 2026-2033): 6.4%

Pneumonia Diagnostics Market - Report Scope

The pneumonia diagnostics market encompasses kits, reagents, and instruments used to detect bacterial, viral, and atypical pneumonia across multiple care settings. Applications include community-acquired, hospital-acquired, and ventilator-associated pneumonia diagnosis. End-users span hospitals, diagnostic centers, and specialty clinics utilizing molecular assays, immunodiagnostics, antigen-based tests, and multiplex PCR platforms.

Market Growth Drivers

Rising disease burden and increased hospitalization rates among elderly and immunocompromised populations. Growing adoption of rapid molecular diagnostics and multiplex PCR panels. Heightened awareness of antimicrobial resistance necessitating accurate pathogen identification. Increased ICU admissions and critical care requirements driving diagnostic demand.

Market Restraints

High cost of advanced molecular diagnostic platforms and infrastructure investments. Limited diagnostic infrastructure in rural and underdeveloped healthcare settings. Insufficient reimbursement coverage for advanced diagnostics in developing regions.

Market Opportunities

Expansion of point-of-care and rapid diagnostic tests enabling decentralized testing. Growing demand for syndromic respiratory panels for simultaneous pathogen detection. Development of affordable diagnostic solutions for price-sensitive emerging markets.

Key Questions Answered in the Report

- What are the major factors driving global demand for pneumonia diagnostics?
- Which product segments and applications are fueling Pneumonia Diagnostics market growth?
- How is North America, 47.3% shaping the Pneumonia Diagnostics market landscape?
- Who are the leading players in the pneumonia diagnostics market, and what strategies are they adopting?
- What are the emerging trends and long-term growth prospects for the global Pneumonia Diagnostics market?

Competitive Intelligence and Business Strategy

Leading players in the pneumonia diagnostics market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Investments in advanced technologies and vertical integration help ensure consistent product quality and supply reliability. Companies are also prioritizing long-term customer relationships and geographic expansion, while emphasizing sustainability, operational efficiency, and cost optimization to gain a competitive edge.

Key Companies Profiled

- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- BIOMÉRIEUX
- Eisai Co., Ltd.
- Xiamen Wiz Biotech Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- AdvaCare Pharma
- Jiangsu BioPerfectus Technologies Co., Ltd.
- Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
- WELLS BIO INC.
- Avecon Healthcare
- Angstrom Biomedicals Pvt. Ltd.
- Revvity

Market Segmentation

By Product
- Kits and Reagents
- Instruments

By Pathogen
- Bacterial Pneumonia
- Atypical Pneumonia
- Viral Pneumonia
- Others

By Setting of Acquisition
- Community-Acquired Pneumonia (CAP)
- Hospital-Acquired Pneumonia (HAP)
- Ventilator-Associated Pneumonia (VAP)

By End-user
- Hospitals
- Diagnostic Centers
- Specialty Clinics

By Region
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Pneumonia Diagnostics Market Snapshot, 2026 and 2033
1.2. Market Opportunity Assessment, 2026-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Pneumonia Diagnostics Market: Value Chain
2.4.1. List of Raw Material Suppliers
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. Profitability Analysis
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. PESTLE Analysis
2.8. Porter Five Force’s Analysis
2.9. Geopolitical Tensions: Market Impact
2.10. Regulatory and Application Landscape
3. Macro-Economic Factors
3.1. Global Sectorial Outlook
3.2. Global GDP Growth Outlook
3.3. Global Parent Market Overview
4. Price Trend Analysis, 2020-2033
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Prices By Product Type/Composition/Application
4.4. Regional Prices and Product Preferences
5. Global Pneumonia Diagnostics Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
5.1. Key Highlights
5.1.1. Market Size and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size Analysis, 2020-2025
5.2.2. Current Market Size Forecast, 2026-2033
5.3. Global Pneumonia Diagnostics Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume Analysis By Product, 2020-2025
5.3.3. Current Market Size (US$ Mn) and Volume Forecast By Product, 2026-2033
5.3.3.1. Kits and Reagents
5.3.3.2. Instruments
5.4. Market Attractiveness Analysis: Product
5.5. Global Pneumonia Diagnostics Market Outlook: Pathogen
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) and Volume Analysis By Pathogen, 2020-2025
5.5.3. Current Market Size (US$ Mn) and Volume Forecast By Pathogen, 2026-2033
5.5.3.1. Bacterial Pneumonia
5.5.3.2. Atypical Pneumonia
5.5.3.3. Viral Pneumonia
5.5.3.4. Others
5.6. Market Attractiveness Analysis: Pathogen
6. Global Pneumonia Diagnostics Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2020-2025
6.3. Current Market Size (US$ Mn) and Volume Forecast By Region, 2026-2033
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia & Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Pneumonia Diagnostics Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
7.3.1. By Country
7.3.2. By Product
7.3.3. By Pathogen
7.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
7.4.1. U.S.
7.4.2. Canada
7.5. Current Market Size (US$ Mn) and Volume Forecast By Product, 2026-2033
7.5.1. Kits and Reagents
7.5.2. Instruments
7.6. Current Market Size (US$ Mn) and Volume Forecast By Pathogen, 2026-2033
7.6.1. Bacterial Pneumonia
7.6.2. Atypical Pneumonia
7.6.3. Viral Pneumonia
7.6.4. Others
7.7. Market Attractiveness Analysis
8. Europe Pneumonia Diagnostics Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
8.3.1. By Country
8.3.2. By Product
8.3.3. By Pathogen
8.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
8.4.1. Germany
8.4.2. France
8.4.3. U.K.
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Rest of Europe
8.5. Current Market Size (US$ Mn) and Volume Forecast By Product, 2026-2033
8.5.1. Kits and Reagents
8.5.2. Instruments
8.6. Current Market Size (US$ Mn) and Volume Forecast By Pathogen, 2026-2033
8.6.1. Bacterial Pneumonia
8.6.2. Atypical Pneumonia
8.6.3. Viral Pneumonia
8.6.4. Others
8.7. Market Attractiveness Analysis
9. East Asia Pneumonia Diagnostics Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
9.3.1. By Country
9.3.2. By Product
9.3.3. By Pathogen
9.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.5. Current Market Size (US$ Mn) and Volume Forecast By Product, 2026-2033
9.5.1. Kits and Reagents
9.5.2. Instruments
9.6. Current Market Size (US$ Mn) and Volume Forecast By Pathogen, 2026-2033
9.6.1. Bacterial Pneumonia
9.6.2. Atypical Pneumonia
9.6.3. Viral Pneumonia
9.6.4. Others
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Pneumonia Diagnostics Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
10.3.1. By Country
10.3.2. By Product
10.3.3. By Pathogen
10.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
10.4.1. India
10.4.2. Southeast Asia
10.4.3. ANZ
10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Mn) and Volume Forecast By Product, 2026-2033
10.5.1. Kits and Reagents
10.5.2. Instruments
10.6. Current Market Size (US$ Mn) and Volume Forecast By Pathogen, 2026-2033
10.6.1. Bacterial Pneumonia
10.6.2. Atypical Pneumonia
10.6.3. Viral Pneumonia
10.6.4. Others
10.7. Market Attractiveness Analysis
11. Latin America Pneumonia Diagnostics Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
11.3.1. By Country
11.3.2. By Product
11.3.3. By Pathogen
11.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Mn) and Volume Forecast By Product, 2026-2033
11.5.1. Kits and Reagents
11.5.2. Instruments
11.6. Current Market Size (US$ Mn) and Volume Forecast By Pathogen, 2026-2033
11.6.1. Bacterial Pneumonia
11.6.2. Atypical Pneumonia
11.6.3. Viral Pneumonia
11.6.4. Others
11.7. Market Attractiveness Analysis
12. Middle East & Africa Pneumonia Diagnostics Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
12.3.1. By Country
12.3.2. By Product
12.3.3. By Pathogen
12.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
12.4.1. GCC
12.4.2. South Africa
12.4.3. Northern Africa
12.4.4. Rest of Middle East & Africa
12.5. Current Market Size (US$ Mn) and Volume Forecast By Product, 2026-2033
12.5.1. Kits and Reagents
12.5.2. Instruments
12.6. Current Market Size (US$ Mn) and Volume Forecast By Pathogen, 2026-2033
12.6.1. Bacterial Pneumonia
12.6.2. Atypical Pneumonia
12.6.3. Viral Pneumonia
12.6.4. Others
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.2.3. Apparent Production/Service Capacity
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Thermo Fisher Scientific Inc.
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Bio-Rad Laboratories, Inc.
13.3.3. BIOMÉRIEUX
13.3.4. Eisai Co., Ltd.
13.3.5. Xiamen Wiz Biotech Co., Ltd.
13.3.6. F. Hoffmann-La Roche Ltd.
13.3.7. AdvaCare Pharma
13.3.8. Jiangsu BioPerfectus Technologies Co., Ltd.
13.3.9. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
13.3.10. WELLS BIO INC.
13.3.11. Avecon Healthcare
13.3.12. Angstrom Biomedicals Pvt. Ltd.
13.3.13. Revvity
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations